Regulation of erythropoiesis in patients with suppressed hematopoiesis during mountain climatic treatment
- Authors: Ismailova A.Z.1, Makeshova A.B.1, Eralieva M.O.1, Levina A.A.1, Mamukova Y.I.1, Raimzhanov A.R.1, Ismailova AZ2, Makeshova AB3, Eraliyeva MO3, Levina AA4, Mamukova Y.I4, Raimzhanov AR3
-
Affiliations:
- Kirghiz Hematology Research CenterHematology Research Center
- Kirghiz Hematology Research Center
- Hematology Research Center
- Issue: Vol 82, No 1 (2010)
- Pages: 39-42
- Section: Editorial
- Submitted: 13.04.2020
- Published: 15.01.2010
- URL: https://ter-arkhiv.ru/0040-3660/article/view/33390
- ID: 33390
Cite item
Full Text
Abstract
Subjects and methods. The investigation included 12 patients with aplastic anemia (AA) and 10 with idiopathic thrombocytopenic purpura (ITP). Blood was received at a Bishkek hospital, then on days 20 and 40 of stay in the mountains. The authors studied erythropoietin (EPO) by enzyme immunoassay (Protein Contour kit, Russia), serum ferritin (SF) by immunoradioassay (Immunotech kit, Czech Republic), hypoxia-inducible factor-1α (HIF-1α), homocysteine (HC), hepcidin, endothelin (ET), and thrombomodulin (TM) by sandwich enzyme immunoassay, by applying monospecific antisera and monoclonal antibodies against relevant antigens (IDG Int Inc, USA).
Results. On staying in the mountains, there was a gradual increase in the content of hemoglobin in patients with AA and ITP. On day 40, in keeping with higher hemoglobin (Hb) levels, both groups showed a decrease in HIF-1α concentrations to the normal values (from 8.2 to 4.5 pg/ml). Due to the anemic syndrome, baseline EPO was increased by 5-7 times in the patients from both groups. On days 20-40, the content of EPO showed a 1.3-2.5-fold increase. In AA, HC was almost 3 times greater than the normal values; in ITP, it was 1.5-fold increased. On day 20 and during the patients' stay in the mountains, the level of HC remained in the normal range in both groups.
Conclusion. Hypoxic hypoxia positively affects a number of hematological parameters, by normalizing erythropoiesis (Hb, EPO, and HIF-1α), iron metabolism (SF), and the coagulation system (HC, ET, and TM).
About the authors
Asel' Zarlykovna Ismailova
Email: aselismailova@mail.ru
Aynura Bekbolotovna Makeshova
Email: ainuramak@mail.ru
Mepi Omopovna Eralieva
Email: meeri.e@mail.ru
Alla Arkad'evna Levina
Email: yullevina@yandex.ru
Yuliya Iosifovnna Mamukova
Email: hloe6@rambler.ru
Abdukhalim Raimzhanovich Raimzhanov
A Z Ismailova
Kirghiz Hematology Research CenterHematology Research CenterKirghiz Hematology Research CenterHematology Research Center
A B Makeshova
Kirghiz Hematology Research CenterKirghiz Hematology Research Center
M O Eraliyeva
Kirghiz Hematology Research CenterKirghiz Hematology Research Center
A A Levina
Hematology Research CenterHematology Research Center
Yu I Mamukova
Hematology Research CenterHematology Research Center
A R Raimzhanov
Kirghiz Hematology Research CenterKirghiz Hematology Research Center
References
- Агаджанян Н. А., Марачев А. Г. Экологическая физиология человека. М., 1999.
- Раимжанов А. Р. Апластическая анемия и горный климат. Бишкек; 2005.
- Kemma N. E., Pikkers P., Nemeth E. et al. Time-course analysis of hepcidin, serum iron and plasma cytokine levels in human injected with LPS. Blood 2005; 106 (5): 1864-1866.
- Papanikolaou G., Tzilianos M. Hepcidin in iron overload disorders. Blood 2005; 105 (10): 4103-4105.
- Donghoon Yoon, Pastore Y. D. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J. Biol. Chem. 2006; 281 (35): 25703-25711.
- Clarke R., Siansbie D. Assessment of homocysteine as a cardiovascular risk factor in clinical practice. Ann. Clin. Biochem. 2001; 38: 624-632.
- Nacone N. A. The peroxidase conjugates for immunoenzyme method. J. Biol. Chem 1965; 85: 585-587.
- Цветаева Н. В., Левина А. А. Иммуноферментный метод определения гомоцистеина. Патогенез 2005; 2: 48-51.
- Андреева А. П., Замчий А. А. и др. Особенности обмена железа в условиях горного климата. В кн.: II съезд гематологов и трансфузиологов. М., 1989: 356.